drugset / Trial / NCT03349606
Cocaine Use Disorder and Cortical Dopamine
Phase 0
Completed
30 enrolled
University of Pittsburgh
National Institute on Drug Abuse (NIDA) · collab
Non-randomizedParallel-groupOpen-labelBasic science
Summary
The goal of this study is to use \[C-11\]FLB 457 and amphetamine (oral, 0.5 mg/kg) to measure cortical dopamine transmission in cocaine dependent individuals and healthy controls
Timeline
- Start
- 2010-06-02
- Primary completion
- 2019-09-24
- Completion
- 2020-06-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dextroamphetamine | Small molecule | 0.5 mg/kg | Oral |